Alain Bousquet-Mélou

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet, Pierre-Louis Toutain, Peggy Gandia, 2019, Clinical Pharmacokinetics.

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Pierre-Louis Toutain, Didier Concordet, Peggy Gandia, 2019, Clinical Pharmacokinetics.

Species differences in pharmacokinetics and pharmacodynamics.

Alain Bousquet-Mélou, Aude Ferran, P. Toutain, 2010, Handbook of experimental pharmacology.